ATE429901T1 - Selbstformende thermodynamisch stabile liposome - Google Patents

Selbstformende thermodynamisch stabile liposome

Info

Publication number
ATE429901T1
ATE429901T1 AT01992326T AT01992326T ATE429901T1 AT E429901 T1 ATE429901 T1 AT E429901T1 AT 01992326 T AT01992326 T AT 01992326T AT 01992326 T AT01992326 T AT 01992326T AT E429901 T1 ATE429901 T1 AT E429901T1
Authority
AT
Austria
Prior art keywords
thermodynamically stable
self
stable liposomes
forming thermodynamically
liposomes
Prior art date
Application number
AT01992326T
Other languages
English (en)
Inventor
Dan Lasic
Brian Keller
Original Assignee
Biozone Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24996074&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE429901(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biozone Lab Inc filed Critical Biozone Lab Inc
Application granted granted Critical
Publication of ATE429901T1 publication Critical patent/ATE429901T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01992326T 2000-12-20 2001-12-19 Selbstformende thermodynamisch stabile liposome ATE429901T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/745,292 US6610322B1 (en) 2000-12-20 2000-12-20 Self forming, thermodynamically stable liposomes and their applications
PCT/US2001/050118 WO2002049617A2 (en) 2000-12-20 2001-12-19 Self forming, thermodynamically stable liposomes and their applications

Publications (1)

Publication Number Publication Date
ATE429901T1 true ATE429901T1 (de) 2009-05-15

Family

ID=24996074

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01992326T ATE429901T1 (de) 2000-12-20 2001-12-19 Selbstformende thermodynamisch stabile liposome

Country Status (7)

Country Link
US (5) US6610322B1 (de)
EP (1) EP1343475B1 (de)
JP (2) JP4497765B2 (de)
AT (1) ATE429901T1 (de)
AU (1) AU2002232788A1 (de)
DE (1) DE60138566D1 (de)
WO (1) WO2002049617A2 (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7230088B2 (en) 2001-07-03 2007-06-12 Mallinckrodt, Inc. Compounds for dual photodiagnosis and therapy
US6656451B1 (en) * 2000-10-16 2003-12-02 Mallinckrodt, Inc. Indole compounds as novel dyes for organ function monitoring
US6669926B1 (en) * 2000-10-16 2003-12-30 Mallinckrodt, Inc. Hydrophilic light absorbing indole compounds for determination of physiological function in critically ill patients
US6673334B1 (en) * 2000-10-16 2004-01-06 Mallinkcrodt, Inc. Light sensitive compounds for instant determination of organ function
US6610322B1 (en) * 2000-12-20 2003-08-26 Brian Charles Keller Self forming, thermodynamically stable liposomes and their applications
US20030077829A1 (en) * 2001-04-30 2003-04-24 Protiva Biotherapeutics Inc.. Lipid-based formulations
WO2002087543A1 (en) * 2001-05-01 2002-11-07 Biozone Laboratories, Inc. Sustained release formulations for nifedipine, dextromethorphan, and danazol
CN1245153C (zh) * 2002-06-06 2006-03-15 上海家化联合股份有限公司 一种维生素a脂质体及其制备方法
US7785623B2 (en) * 2002-10-01 2010-08-31 Keller Brian C Compositions and methods useful for the reduction of fine lines and wrinkles
US20060222694A1 (en) * 2003-06-27 2006-10-05 Oh Choon K Stabilized topotecan liposomal composition and methods
EP1559790A1 (de) * 2004-02-02 2005-08-03 International University Bremen Gmbh Vesikel zum Abtrennen von Substanzen aus flüssigen Medien
US8664392B2 (en) 2004-12-23 2014-03-04 Medibeacon, LLC Pyrazine derivatives for bioconjugation
WO2007149479A1 (en) 2006-06-22 2007-12-27 Mallinckrodt Inc. Pyrazine derivatives and uses thereof in renal monitoring
WO2006132388A1 (en) * 2005-06-06 2006-12-14 Waseda University Bone marrow-directing drug delivery materials and their applications
US20070009467A1 (en) * 2005-07-05 2007-01-11 Biozone Laboratories, Inc. Spray-on makeup to simulate the appearance of wearing hosiery
AU2007224084A1 (en) * 2006-03-02 2007-09-13 Mallinckrodt Inc. Thiadiazole compounds and their use in phototherapy
CA2645456A1 (en) * 2006-03-10 2007-09-20 Mallinckrodt Inc. Photoactive compounds and compositions and uses thereof
WO2007115132A2 (en) * 2006-03-29 2007-10-11 Guilford F Timothy Radiopharmaceutical in self-forming liposomal formulation capable of multipath administration including other ingredients
US7794595B2 (en) * 2006-08-28 2010-09-14 Brian Charles Keller Method for encapsulation, remediation and recovery of spilled oil
CA2600220C (en) * 2006-09-07 2014-12-09 Canadian Blood Services Surface cross-linked lipidic particles, methods of production and uses therefor
CA2680279A1 (en) * 2007-03-08 2008-09-12 Biozone Laboratories Inc. Dressing formulations to prevent and reduce scarring
US20080241233A1 (en) * 2007-03-28 2008-10-02 Portola Pharmaceuticals, Inc. Targeted delivery and expression of procoagulant hemostatic activity
US20090035236A1 (en) * 2007-07-31 2009-02-05 Maes Daniel H Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And An Oil Phase Structuring Agent
US20090035240A1 (en) * 2007-07-31 2009-02-05 Maes Daniel H Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent
US8344024B2 (en) * 2007-07-31 2013-01-01 Elc Management Llc Anhydrous cosmetic compositions containing resveratrol derivatives
US8080583B2 (en) * 2007-07-31 2011-12-20 Elc Management Llc Emulsion cosmetic compositions containing resveratrol derivatives and linear or branched silicone
US9295621B2 (en) * 2007-07-31 2016-03-29 Elc Management Llc Emulsion cosmetic compositions containing resveratrol derivatives and silicone surfactant
CN101854903B (zh) * 2007-09-08 2012-07-04 Elc管理有限责任公司 阿魏酸白藜芦醇酯化合物、包含该化合物的组合物及其使用方法
US20090176795A1 (en) * 2008-01-04 2009-07-09 Brian Charles Keller Enhanced delivery of antifungal agents
JP2011508780A (ja) * 2008-01-04 2011-03-17 ケラー，ブライアン，チャールズ 抗真菌薬の増強された送達
US20090291132A1 (en) * 2008-01-04 2009-11-26 Brian Charles Keller Enhanced delivery of antifungal agents
EP2254546A4 (de) * 2008-02-20 2014-07-09 Elc Man Llc Topische zusammensetzungen und verfahren zur hautbleichung
JP2011528377A (ja) * 2008-07-17 2011-11-17 レヴィス，ジョージア 座瘡治療のための方法及び物質
EP2343980A4 (de) * 2008-09-08 2012-06-06 Nian Wu Triazolfungizide
US8524258B2 (en) * 2008-12-22 2013-09-03 Johnson & Johnson Consumer Companies, Inc. Structured lotions
US20100210518A1 (en) * 2009-01-23 2010-08-19 Brian Charles Keller Peg-lipid conjugates for increasing the solubility of drug compounds
WO2010135714A2 (en) 2009-05-22 2010-11-25 The Methodist Hospital Research Institute Methods for modulating adipocyte expression using microrna compositions
WO2010141068A1 (en) * 2009-06-02 2010-12-09 Wu Nian Opthalmic compositions of cyclosporin
CN102480969A (zh) * 2009-07-09 2012-05-30 科锐医疗有限公司 伤口愈合和瘢痕调制方法
US20110105387A1 (en) * 2009-09-19 2011-05-05 Nian Wu Method of treatment with rapamycin
CO6280050A1 (es) * 2010-06-08 2011-05-20 Sante S A Lab Forma farmaceutica de inhibidores de la fosfodiesterasa para administracion transmucosa
US9352291B2 (en) 2011-09-23 2016-05-31 The University Of Southern Mississippi Dispersant for spilled oil
US9775803B2 (en) 2011-10-19 2017-10-03 Samsung Electronics Co., Ltd. Liposome comprising elastin-like polypeptide and tumor cell targeting material and use thereof
EP2874640A4 (de) 2012-01-05 2016-10-26 Frederick Timothy Guilford Liposomal verkapseltes reduziertes glutathion zur behandlung von krebs, einschliesslich mit anderen pharmazeutischen zusammensetzungen
WO2013103840A1 (en) 2012-01-05 2013-07-11 Guilford Frederick Timothy Anti-cancer composition and method utilizing 3-bp and liposomal reduced glutathione
US11458199B2 (en) 2012-08-21 2022-10-04 Opko Pharmaceuticals, Llc Liposome formulations
BR112015003658B1 (pt) 2012-08-21 2022-09-27 Opko Pharmaceuticals, Llc Formulação oftálmica, uso da dita formulação no tratamento de doença oftálmica do segmento posterior, formulação de lipossomas e suspensão oftálmica lipossomal
US20140328898A1 (en) * 2013-03-15 2014-11-06 Children's National Medical Center Nano-Liposomal Formulations and Methods of Use
US9616132B2 (en) 2013-03-15 2017-04-11 Dow Pharmaceutical Sciences, Inc. Kinetin/zeatin topical formulation
ES2933563T3 (es) 2015-04-16 2023-02-10 Symrise Ag Uso de una composición de liposoma
EP3324993B1 (de) 2015-07-21 2024-09-04 Emory University Liposomales reduziertes glutathion zur behandlung des rsv
JP6924431B2 (ja) * 2015-10-13 2021-08-25 株式会社ケーナインラボ ヒトを除く哺乳動物への薬剤の投与方法
US9981041B2 (en) 2016-08-23 2018-05-29 Ira Jason Salzman Ophthalmic lubricating spray
US10702475B2 (en) 2017-09-05 2020-07-07 Richard Rigg Liposome containing compositions and their use in personal care and food products
JP6297737B1 (ja) * 2017-09-25 2018-03-20 ジェイ−ネットワーク，インコーポレイテッド 正に帯電した荷電ニオソームの調製方法及び荷電ニオソーム
CN108392637B (zh) * 2018-03-30 2021-05-18 浙江海昶生物医药技术有限公司 一种泊沙康唑脂质体及其制备方法
JP6860739B1 (ja) 2020-11-20 2021-04-21 ジェイ−ネットワーク，インコーポレイテッド 表皮内の抗酸化物質の発現増強剤

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79114A (en) 1985-08-07 1990-09-17 Allergan Pharma Method and composition for making liposomes
US5358714A (en) * 1988-03-23 1994-10-25 Unilever Patent Holdings B.V. Cosmetic composition
US5225212A (en) * 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
US5720973A (en) 1993-02-18 1998-02-24 Knoll Aktiengesellschaft Preparation of colloidal aqueous solutions of active substances of low solubility and a lipid therefor
US5415869A (en) * 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
DE4410238A1 (de) * 1994-03-25 1995-09-28 Beiersdorf Ag Hautpflegemittel
JPH07316040A (ja) * 1994-03-29 1995-12-05 Res Dev Corp Of Japan 再構成リポソームと物質導入方法
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
US5820873A (en) * 1994-09-30 1998-10-13 The University Of British Columbia Polyethylene glycol modified ceramide lipids and liposome uses thereof
IT1270678B (it) * 1994-10-20 1997-05-07 Bayer Ag Liposomi al chetoprofen
US5859228A (en) * 1995-05-04 1999-01-12 Nexstar Pharmaceuticals, Inc. Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
US6284267B1 (en) * 1996-08-14 2001-09-04 Nutrimed Biotech Amphiphilic materials and liposome formulations thereof
US6110492A (en) * 1997-05-28 2000-08-29 Jenner Biotherapies, Inc. Immunogenic compositions
AU7983798A (en) * 1997-06-23 1999-01-04 Sequus Pharmaceuticals, Inc. Liposome-entrapped polynucleotide composition and method
US6734171B1 (en) * 1997-10-10 2004-05-11 Inex Pharmaceuticals Corp. Methods for encapsulating nucleic acids in lipid bilayers
JP2000229815A (ja) * 1999-02-05 2000-08-22 Toshimitsu Hattori リポソームおよびその利用
JP4444385B2 (ja) * 1999-02-25 2010-03-31 帝人株式会社 リポソーム用時調製用キット
CA2370690A1 (en) * 1999-04-20 2000-10-26 The University Of British Columbia Cationic peg-lipids and methods of use
CO5170451A1 (es) * 1999-04-23 2002-06-27 Kimberly Clark Co Panos limpiadores humedos que tienen beneficios de salud para la piel
US6610322B1 (en) * 2000-12-20 2003-08-26 Brian Charles Keller Self forming, thermodynamically stable liposomes and their applications
US7785623B2 (en) * 2002-10-01 2010-08-31 Keller Brian C Compositions and methods useful for the reduction of fine lines and wrinkles

Also Published As

Publication number Publication date
US7718190B2 (en) 2010-05-18
US20070042032A1 (en) 2007-02-22
DE60138566D1 (en) 2009-06-10
US20110064791A1 (en) 2011-03-17
JP4497765B2 (ja) 2010-07-07
WO2002049617A3 (en) 2003-01-23
EP1343475A2 (de) 2003-09-17
JP2010001318A (ja) 2010-01-07
US6610322B1 (en) 2003-08-26
WO2002049617A2 (en) 2002-06-27
AU2002232788A1 (en) 2002-07-01
US20050249797A1 (en) 2005-11-10
EP1343475B1 (de) 2009-04-29
JP2002212106A (ja) 2002-07-31
US6958160B1 (en) 2005-10-25
US7150883B2 (en) 2006-12-19

Similar Documents

Publication Publication Date Title
ATE429901T1 (de) Selbstformende thermodynamisch stabile liposome
WO2002072011A3 (en) Stabilized therapeutic and imaging agents
DE50202328D1 (de) Amidofunktionelle aminopolydiorganosiloxane
TR200202194T2 (tr) Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri
ZA200308270B (en) Liposome composition for improved intracellular delivery of a therapeutic agent.
IL152593A0 (en) Liposome drug delivery
HUP0300882A3 (en) New self emulsifying drug delivery system
AU2002236062A8 (en) Lipids, lipid compositions, liposomes, and lipoplexes
BR0112375A (pt) Métodos de sìntese para aplidina e novos derivados antitumorais, métodos para fabrica-los e usá-los.
MXPA03008856A (es) Metodos para la produccion de lipido a 3-o-desacilado-4¦-monofosforilo (3d-mla).
MXPA02012068A (es) Formulaciones liposomales inhibidoras de la timidilato de benzoqunazolina sintasa.
IL151380A0 (en) New self emulsifying drug delivery system
CY1108791T1 (el) Φυτοενδυναμωτικο μεσον
DK1259250T3 (da) Endoparasiticide midler
ATE318834T1 (de) Lipide mit aminoxygruppe
BR0101437A (pt) Método para preparar um ciclopropeno
IL156331A0 (en) A process for the preparation of paclitaxel
DK1351972T3 (da) Lipider omfattende en aminoxygruppe
DE50208813D1 (en) (ester)-lysolecithine in liposomen
DE10295446D2 (de) Narkosegerät
ITMI20001483A0 (it) Macchina per la fabbricazione di cartone ondulato.
AU2001279975A1 (en) Pump source for lasers
IT1315064B1 (it) Modulo per la formazione di pianali di macchine sezionatrici
NO20013067L (no) Underholdningsmaskin
FI20002533A (fi) Sähköisten viestien henkilökohtaisuuden osoittaminen teknisellä ratkaisulla

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties